Amgen CEO on cholesterol drug price cut: 'Too many patients' were struggling to pay

Jim Cramer sits down with Amgen Chairman and CEO Bob Bradway to hear about the company's recent price cut for one of its key drugs.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Apple CEO Tim Cook speaks with CNBC's Jim Cramer: Full transcriptApple CEO Tim Cook talked to CNBC's Jim Cramer about iPhone sales, the Chinese economy and the future of Apple.
Read more »

Apple CEO Tim Cook talks China, Wall Street negativity and innovation with CNBC's Jim CramerJim Cramer sits down with Apple CEO Tim Cook to discuss the company's recent guidance cut, U.S.-China trade talks an Apple's 'culture of innovation.'
Read more »

U.S. top court rejects Amgen over cholesterol medication patent fightThe U.S. Supreme Court on Monday declined to take up Amgen Inc's bid to rei...
Read more »

Stocks making the biggest moves after hours: Apple, Amgen, AMD and moreSee which stocks are posting big moves after the bell on January 29.
Read more »